Skip to main content
. 2019 Jun 28;28(2):80–92. doi: 10.1055/s-0039-1692452

Fig. 1.

Fig. 1

The major pathways and the pharmacological treatments targeting them. ATP, adenosine triphosphate; cAMP, cyclic adenosine monophosphate; ET, endothelin; GTP, guanosine triphosphate; GMP, guanosine monophosphate; IP, I-prostanoid receptors; NO, nitric oxide; PDE-5, phosphodiesterase type 5; sGC, soluble guanylate cyclase. Adapted with permission from Prior et al. update on pharmacotherapy for pulmonary hypertension, Med J Aust 2016. 86